HIV drug resistance and its associated factors among patients during interruption of antiretroviral therapy in China

HIV drug resistance and its associated factors among patients during interruption of antiretroviral therapy in China

BackgroundThe prevalence of human immunodeficiency virus (HIV) drug resistance among people living with HIV (PLWH) who experience treatment interruptions is a significant concern. This study aimed to investigate the prevalence and characteristics of HIV drug resistance for PLWH who experienced treat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhongbao Zuo, Wei Huang, Lei Liu, Miaomiao Li, Hongli Chen, Yi Feng, Lingjie Liao, Yiming Shao, Yuhua Ruan, Jing Wu, Hui Xing
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Microbiology
Subjects:	HIV drug resistance interruption of antiretroviral therapy mutation viral load
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2025.1617795/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The impact of a comprehensive strategy on HIV treatment continuum in a highly endemic area of China: an interrupted time series analysis
by: Ruiying Liang, et al.
Published: (2025-04-01)

Progress towards attaining viral suppression among people living with HIV in Burkina Faso, 2018: A Secondary Data Analysis
by: Smaïla Ouédraogo, et al.
Published: (2023-09-01)

Prior antiretroviral therapy exposure among clients presenting for HIV treatment initiation in South Africa: an exploratory mixed-methods study using multiple indicators of exposure
by: Mariet Benade, et al.
Published: (2025-07-01)

High prevalence of low-level viremia among infants initiated on antiretroviral drugs following mother-to-child transmission of HIV
by: Immaculate Nankya, et al.
Published: (2025-03-01)

Determinants of viral load suppression among adolescents on antiretroviral therapy in Eswatini: a cross-sectional study
by: Londiwe D. Hlophe, et al.
Published: (2025-04-01)

Evaluating the Fiscal Impact of Antiretroviral Therapy for the Management of HIV in the United States 1987&ndash;2023
by: Paquete AT, et al.
Published: (2025-05-01)

Characterizing treatment interruptions in the OPERA cohort and virologic outcomes after resumption with bictegravir/emtricitabine/tenofovir alafenamide
by: Karam Mounzer, et al.
Published: (2025-07-01)

PHARMACOECONOMIC MODELING OF ANTIRETROVIRAL DRUGS USE DURING TREATMENT OF HIV INFECTION
by: V. A. Chibilyaev, et al.
Published: (2015-03-01)

Prevalence of acquired resistance to antiretrovirals in children and adolescents living with HIV under clinical follow-up at the Roosevelt Hospital in Guatemala
by: S. Alonso, et al.
Published: (2025-09-01)

Development of machine learning algorithms to predict viral load suppression among HIV patients in Conakry (Guinea)
by: Degninou Yehadji, et al.
Published: (2025-03-01)

Expanding Treatment Opportunities: Reviewing the Current State of Injectable Antiretrovirals for Treatment of HIV
by: Amanda Binkley, et al.
Published: (2024-10-01)

Factors affecting viral suppression or rebound in people living with HIV and receiving antiretroviral therapy in Ghana
by: Anthony T. Boateng, et al.
Published: (2025-03-01)

Feasibility and staff acceptability of implementing Xpert HIV-1 viral load point-of-care testing: a pilot study in San Francisco
by: Kelvin Moore Jr., et al.
Published: (2025-01-01)

Immune-virological status in people with HIV from naïve to six months on cART at Ahmadu Bello University Teaching Hospital Zaria, Nigeria.
by: Yusuf Aminu* 1, Bolanle O.P. Musa 2, Haruna M. Muktar 2, Aliyu Babadoko 2, Abdullahi A. Mohammed 2, Ahmad E. Abdurrahman 2
Published: (2024-11-01)

Viral load suppression rate of third-line antiretroviral therapy and its association with gender among HIV patients after second-line treatment failure in Africa: a systematic review and meta-analysis
by: Tilahun Degu Tsega, et al.
Published: (2025-02-01)

HIV transmission risk among people living with HIV in Zhejiang Province, China: data from a large cross-sectional study, 2022
by: Lin He, et al.
Published: (2025-04-01)

COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS
by: M. B. Kubaeva, et al.
Published: (2017-08-01)

Adherence and Cost–Utility Analysis of Antiretroviral Treatment in People Living with HIV in a Specialized Clinic in Mexico City
by: Ivo Heyerdahl-Viau, et al.
Published: (2025-05-01)

Time to viral load suppression and its predictors among people living with HIV on antiretroviral therapy in Gebi Resu zone, Afar Region, Ethiopia, 2023
by: Anteneh Tefera Chirnet, et al.
Published: (2024-10-01)

Impact of Delayed Early Antiretroviral Therapy Initiation on Treatment Outcomes in Infant Macaques Exposed to SHIVAD8
by: Li Ma, et al.
Published: (2025-06-01)

Treatment as prevention in resource-limited settings: is it feasible to maintain HIV viral load suppression over time?
by: María Eugenia Socías, et al.
Published: (2013-08-01)

Disease progression and antiretroviral therapy in newly seropositive HIV subjects in a tertiary care hospital in North India
by: Sanjim Chadha, et al.
Published: (2013-02-01)

Clinical observation of an HIV-infected patient heterozygous for the mutant allele of the CCR5 del 32 chemokine receptor
by: Z. I. Akhmedjanova, et al.
Published: (2021-07-01)

ANALYSIS AND OPTIMAL CONTROL OF HIV GROWTH MODEL IN THE BODY WITH ANTIRETROVIRAL THERAPY
by: Erlyana Trie Damayanti, et al.
Published: (2024-05-01)

HIV-1 Antiretroviral Drug Resistance in Mozambique: A Systematic Review and Meta-Analysis
by: Paloma Gonçalves, et al.
Published: (2024-11-01)

Impact of HIV-1 capsid polymorphisms on viral infectivity and susceptibility to lenacapavir
by: Derek Hansen, et al.
Published: (2025-05-01)

The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco
by: Khadija Bakhouch, et al.
Published: (2009-06-01)

Panhypopituitarism in HIV patient receiving antiretroviral therapy
by: Tatyana B. Morgunova, et al.
Published: (2021-12-01)

A study of barriers to adherence of antiretroviral treatment in prisoners living with HIV in Tehran, Iran
by: Seyedahmad Seyedalinaghi, et al.
Published: (2020-06-01)

Prevention of mother-to-child transmission of HIV service interruptions amid COVID-19 pandemic
by: Florence M.Q. Setshedi, et al.
Published: (2024-05-01)

Evaluating predictive performance, validity, and applicability of machine learning models for predicting HIV treatment interruption: a systematic review
by: Williams Kwarah, et al.
Published: (2025-07-01)

Predictors of virological outcomes in patients with HIV on antiretroviral therapy in Osogbo, Nigeria: a cross-sectional study
by: Funso Abidemi Olagunju, et al.
Published: (2025-05-01)

High prevalence of undisclosed antiretroviral drug use among individuals initiating HIV treatment in Gaborone, Botswana
by: Natasha O. Moraka, et al.
Published: (2025-06-01)

Characteristics of HIV-positive pregnant women and HIV- and antiretroviral therapy-exposed fetuses: A case-control study
by: Tung-Che Hung, et al.
Published: (2020-08-01)

IMPROVING ANTIRETROVIRAL THERAPY IN CHILDREN WITH HIV INFECTION
by: V. B. Denisenko, et al.
Published: (2018-07-01)

Opportune moments for task interruptions: examining the cognitive mechanisms underlying interruption-timing effects
by: Patricia Hirsch, et al.
Published: (2025-01-01)

Prevalence and determinants of nonadherence to highly active antiretroviral therapy among people living with HIV/AIDS in Ibadan, Nigeria
by: Samuel A. Olowookere, et al.
Published: (2008-10-01)

STUDY OF SUPPRESSION OF HIV VIRAL LOAD AMONG PEOPLE RECEIVING ANTIRETROVIRAL THERAPY IN PALEMBANG CITY
by: Adeleine Silva Vanessa, et al.
Published: (2024-09-01)

Association between differentiated HIV care delivery model and low-level viremia among people living with HIV in Rwanda
by: Jackson Sebeza, et al.
Published: (2024-11-01)

Adherence to antiretroviral therapy among HIV patients at a hospital in Tacna, Peru
by: Brayan Miranda-Chavez, et al.
Published: (2024-11-01)